Sporanox patent ruling
Executive Summary
Trial court's ruling that Eon's generic Sporanox (itraconazole) does not infringe a Janssen patent affirmed by the Federal Circuit June 13. Eon launched its generic in February with 180 days of marketing exclusivity (1"The Pink Sheet" Feb. 14, 2005, In Brief)...
You may also be interested in...
Sporanox generic launches
Eon launches first generic of Janssen's antifungal Sporanox (itraconazole) Feb. 9. Eon, which holds 180-day marketing exclusivity on itraconazole 100 mg capsules, received ANDA approval in May but was barred from launching by a temporary restraining order in Janssen's patent infringement lawsuit (1"The Pink Sheet" June 7, 2004, In Brief). A federal judge ruled in July that Eon's ANDA does not infringe; the case is under appeal. Eon says it timed its launch for the start of the heavy prescribing season for itraconazole...
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.